BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 19944686)

  • 1. Protection of human corneal epithelial cells from hypoxia-induced disruption of barrier function by hepatocyte growth factor.
    Kimura K; Teranishi S; Kawamoto K; Nishida T
    Exp Eye Res; 2010 Feb; 90(2):337-43. PubMed ID: 19944686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of dexamethasone against hypoxia-induced disruption of barrier function in human corneal epithelial cells.
    Kimura K; Teranishi S; Kawamoto K; Nishida T
    Exp Eye Res; 2011 May; 92(5):388-93. PubMed ID: 21354133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1beta-induced disruption of barrier function in cultured human corneal epithelial cells.
    Kimura K; Teranishi S; Nishida T
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):597-603. PubMed ID: 19171646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of human corneal epithelial cells from hypoxia-induced disruption of barrier function by keratinocyte growth factor.
    Teranishi S; Kimura K; Kawamoto K; Nishida T
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2432-7. PubMed ID: 18362114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide.
    Kimura K; Morita Y; Orita T; Haruta J; Takeji Y; Sonoda KH
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2572-760. PubMed ID: 23482463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-alpha in a manner dependent on NF-kappaB.
    Kimura K; Teranishi S; Fukuda K; Kawamoto K; Nishida T
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):565-71. PubMed ID: 18235000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function.
    Hopkins AM; Walsh SV; Verkade P; Boquet P; Nusrat A
    J Cell Sci; 2003 Feb; 116(Pt 4):725-42. PubMed ID: 12538773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corneal epithelial tight junctions and their response to lipopolysaccharide challenge.
    Yi X; Wang Y; Yu FS
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4093-100. PubMed ID: 11095601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-155-5p Reduces Corneal Epithelial Permeability by Remodeling Epithelial Tight Junctions during Corneal Wound Healing.
    Wang F; Wang D; Song M; Zhou Q; Liao R; Wang Y
    Curr Eye Res; 2020 Aug; 45(8):904-913. PubMed ID: 31852252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional alteration of corneal epithelial barrier under inflammatory conditions.
    Contreras-Ruiz L; Schulze U; García-Posadas L; Arranz-Valsero I; López-García A; Paulsen F; Diebold Y
    Curr Eye Res; 2012 Nov; 37(11):971-81. PubMed ID: 22738643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebamipide increases barrier function and attenuates TNFα-induced barrier disruption and cytokine expression in human corneal epithelial cells.
    Tanaka H; Fukuda K; Ishida W; Harada Y; Sumi T; Fukushima A
    Br J Ophthalmol; 2013 Jul; 97(7):912-6. PubMed ID: 23603753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood-brain barrier under hypoxia/reoxygenation.
    Torii H; Kubota H; Ishihara H; Suzuki M
    Pharmacol Res; 2007 Feb; 55(2):104-10. PubMed ID: 17157525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.
    Musch MW; Walsh-Reitz MM; Chang EB
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G222-31. PubMed ID: 16239402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of tight-junctional proteins in corneal epithelial cells by corneal fibroblasts in collagen vitrigel cultures.
    Ko JA; Liu Y; Yanai R; Chikama T; Takezawa T; Nishida T
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):113-9. PubMed ID: 18172082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells.
    Yeo NK; Jang YJ
    Laryngoscope; 2010 Feb; 120(2):346-52. PubMed ID: 20013846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP and acidic fibroblast growth factor have opposing effects on tight and adherens junctions in microvascular endothelial cells in vitro.
    Dye JF; Leach L; Clark P; Firth JA
    Microvasc Res; 2001 Sep; 62(2):94-113. PubMed ID: 11516239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK is involved in EGF-mediated protection of tight junctions, but not adherens junctions, in acetaldehyde-treated Caco-2 cell monolayers.
    Samak G; Aggarwal S; Rao RK
    Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G50-9. PubMed ID: 21474650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions.
    Qasim M; Rahman H; Ahmed R; Oellerich M; Asif AR
    Exp Cell Res; 2014 Apr; 322(2):277-89. PubMed ID: 24509232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of blood-testis barrier dynamics: an in vivo study.
    Wong CH; Mruk DD; Lui WY; Cheng CY
    J Cell Sci; 2004 Feb; 117(Pt 5):783-98. PubMed ID: 14734653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.